Ingevity Corporation

NYSE:NGVT

Chemicals - Specialty

Basic Materials
$58.31 +1.13%

+$0.81 today

Market cap
$1.97B
Beta
1.19
P/E (TTM)
-20.0
EPS (TTM)
-$3.62
52W Low $39.74High $79.29

Volume 0.37M

Average 0.26M

NGVT Other Investing Activities

Investing cash flows not reported separately.

Ingevity CorporationNYSE: NGVT

Other Investing Activities · Q3 FY2026 · quarter ended Sep 2026

Other investing activities turns positive

Q3 FY2026 other investing activities was $2.5M, compared with -$16.2M a year earlier. Trailing-twelve-month other investing activities was $4.6M.

Context

  • Other investing activities amounted to 0.3% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Other investing activities increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other investing activities holds near $2.5M or moves back toward the trailing-twelve-month quarterly average of $1.15M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$2.5M+516.7% QoQ
Last fiscal yearDec 2025
$3.6M+325.0% YoY
LTMSep 2026
$4.6M+141.4% YoY
Other Investing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+115.4%——
1 year+325.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Investing Activities history

USD · from the cash flow

Latest · FY2025
3.6M USD
Year-over-year change
+325.0%
4-year CAGR
+63.8%

Other Investing Activities vs competitors

How NGVT compares with its peers on the latest reported figures

  • Peers report in different currencies, so other investing activities is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +141.4% is the 4th highest of 11, against a peer median of +35.8%.
  • Other investing activities amounts to 0.4% of revenue for NGVT, versus a peer median of 1.2%.
NGVT Competitors
Other Investing Activities for NGVT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CCThe Chemours CompanyLTM Jun 2026$301M USD+14950.0%—5.2%
SKESkeena Resources LimitedLTM Sep 2026CA$269.72M CAD+966.7%——
ASHAshland Inc.LTM Jun 2026$34M USD-17.1%-79.2%1.8%
OLNOlin CorporationLTM Jun 2026$31.4M USD-25.8%-50.0%0.5%
KWRQuaker Chemical CorporationLTM Sep 2026$27.59M USD-512.0%+59.6%1.4%
MTXMinerals Technologies Inc.LTM Apr 2026$26.4M USD+77.2%—1.2%
AAUCAllied Gold CorporationLTM Jun 2026$19.27M USD-5.6%—1.3%
FMCFMC CorporationLTM Mar 2026$17.8M USD+361.8%-46.7%0.5%
NGVTIngevity CorporationLTM Sep 2026$4.6M USD+141.4%—0.4%
IOSPInnospec Inc.LTM Jun 2026$1.6M USD-88.7%+137.5%0.1%
ELVRElevra Lithium LimitedFY2025A$0 AUD+100.0%—0.0%
Peer median (excluding NGVT) —+35.8%-46.7%1.2%

Competitors are the stored peer set for NGVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income118.1M211.6M(5.4M)(430.3M)(167.1M)
Depreciation & Amortization109.9M108.8M122.8M108.3M106.4M
Deferred Income Tax(4.6M)(5M)(44.7M)(121.4M)(4.7M)
Stock-Based Compensation12.3M16.1M10.6M11.9M18.3M
Change in Working Capital30.5M(66.5M)(67.8M)(10M)22.7M
Accounts Receivables(13.8M)(42.1M)42.7M38.2M12.2M
Inventory(55.8M)(63.7M)25.8M86.2M40.2M
Accounts Payables14.8M42.7M(14.6M)(63.4M)(2.6M)
Other Working Capital85.3M(3.4M)(121.7M)(71M)(27.1M)
Other Non-Cash Items27.1M48.4M189.6M570.1M355.6M
Operating Cash Flow293.3M313.4M205.1M128.6M331.2M
Capital Expenditures(103.8M)(142.5M)(109.8M)(77.6M)(57.7M)
Acquisitions (Net)0(344.5M)000
Purchases of Investments(35.3M)(77.4M)(2.4M)(300K)(16.4M)
Sales of Investments014.7M31.5M013M
Other Investing Activities500K(2.2M)3.4M(1.6M)3.6M
Investing Cash Flow(138.6M)(551.9M)(77.3M)(79.5M)(57.5M)
Debt Repayment(26M)199M(6.6M)(67.1M)(193.6M)
Common Stock Issued4.7M04.7M01.4M
Common Stock Repurchased(109.4M)(145.2M)(92.1M)(3.1M)(56.3M)
Dividends Paid00000
Other Financing Activities(2.4M)(5.7M)(5.9M)0(3.7M)
Financing Cash Flow(133.1M)48.1M(99.9M)(70.2M)(252.2M)
Effect of Forex Changes(1.7M)(6M)(300K)(4.2M)4.5M
Net Change in Cash19.9M(196.4M)27.6M(25.3M)26M
Free Cash Flow189.5M170.9M95.3M51M273.5M

Ingevity Corporation

NYSE:NGVT

Intrinsic Alpha fair value

Locked

Current Price

$58.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.